Current Assets
Income taxes receivable
Merck & Co. Income taxes receivable increased by 46.2% to $5.70B in Q4 2025 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
An increase may indicate overpayment of estimated taxes or the accrual of refundable credits, representing a potential source of near-term cash inflow.
Detailed definition
This represents the amount of income tax overpayments or refundable tax credits that the company expects to recover from...
Peer comparison
Common for large corporations that manage complex tax filings across multiple jurisdictions.
Metric ID:
income_taxes_receivableHistorical Data
2 periods
| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | $3.90B | $5.70B |
| QoQ Change | — | +46.2% |
| YoY Change | — | +46.2% |
Range$3.90B – $5.70B
Avg YoY Growth+46.2%
Median YoY Growth+46.2%
Income taxes receivable at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s income taxes receivable?
- Merck & Co. (MRK) reported income taxes receivable of $5.70B in Q4 2025.
- What does income taxes receivable mean?
- Tax refunds or credits owed to the company by government tax agencies.